(Q43172296)

15 November 2017

title

High plasma phospholipase A2 activity, inflammation markers, and LDL alterations in obesity with or without type 2 diabetes (English)

1 reference

15 November 2017

1 reference

Fatima Garces

1

1 reference

15 November 2017

Flor López

2

1 reference

15 November 2017

Cladimar Niño

3

1 reference

15 November 2017

Anazita Fernandez

4

1 reference

15 November 2017

Luis Chacin

5

1 reference

15 November 2017

Eva Hurt-Camejo

6

1 reference

15 November 2017

Germán Camejo

7

1 reference

15 November 2017

Rafael Apitz-Castro

8

1 reference

15 November 2017

publication date

4 February 2010

1 reference

15 November 2017

1 reference

15 November 2017

volume

18

1 reference

15 November 2017

issue

10

1 reference

15 November 2017

page(s)

2023-2029

1 reference

Biology of secretory phospholipase A2.

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.9

Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.9

Future role for selective phospholipase A2 inhibitors in the prevention of atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.9

The extracellular matrix on atherogenesis and diabetes-associated vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.9

Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.9

Group V and X secretory phospholipase A(2)s-induced modification of high-density lipoprotein linked to the reduction of its antiatherogenic functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.9

Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.9

Visceral adipose tissue accumulation, secretory phospholipase A2-IIA and atherogenecity of LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.9

Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: relation with lipoprotein-associated phospholipase A2 and effects of simvastatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.9

Lp-PLA2 activity and PLA2G7 A379V genotype in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.9

Circulating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women: the EPIC-Norfolk study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.9

Interfacial kinetic and binding properties of the complete set of human and mouse groups I, II, V, X, and XII secreted phospholipases A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.9

Inhibition of the complete set of mammalian secreted phospholipases A(2) by indole analogues: a structure-guided study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.9

A proteomic study of the apolipoproteins in LDL subclasses in patients with the metabolic syndrome and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.9

Tagging-SNP haplotype analysis of the secretory PLA2IIa gene PLA2G2A shows strong association with serum levels of sPLA2IIa: results from the UDACS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.9

Lipoprotein-matrix interactions in macrovascular disease in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.9

Phospholipase A2 and small, dense low-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.9

Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.9

Potent modification of low density lipoprotein by group X secretory phospholipase A2 is linked to macrophage foam cell formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.9

Atherogenic properties of LDL particles modified by human group X secreted phospholipase A2 on human endothelial cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.9

Impact of a combined treatment of angiotensin II type 1 receptor blockade and 3-hydroxy-3-methyl-glutaryl-CoA-reductase inhibition on secretory phospholipase A2-type IIA and low density lipoprotein oxidation in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.9

Phospholipase A(2) modification of low density lipoproteins forms small high density particles with increased affinity for proteoglycans and glycosaminoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.9

Molecular basis for the association of group IIA phospholipase A(2) and decorin in human atherosclerotic lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.9

Lipolysis of LDL by Human Secretory Phospholipase A 2 Induces Particle Fusion and Enhances the Retention of LDL to Human Aortic Proteoglycans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.9

The Reduction of Inflammatory Biomarkers by Statin, Fibrate, and Combination Therapy Among Diabetic Patients With Mixed Dyslipidemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.9

The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.9

Photometric measurement of lipoprotein-cholesterol after agarose electrophoresis: comparison with single-spin ultracentrifugal analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.9

31 March 2020

Identifiers

DOI

10.1038/OBY.2010.9

1 reference

15 November 2017

1 reference